Clinical observation of the porous tantalum implantation combined with autologous bone marrow stem cell transplantation for the treatment of osteonecrosis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002091

Enrollment

Unknown

Registered

2012-03-28

Start date

2008-04-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis of Femoral Head

Interventions

Experimental group:Porous tantalum implantation combined with autologous bone marrow stem cell transplantation

Control group:Porous tantalum implantation

Eligibility

Sex/Gender

All

Age

12 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Hospitalized patients younger than 65, both men and women; 2. The Steinberg stage is Phase I-II; 3. Subjects guardians and / or subjects is voluntary and informed consent, and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Surgical contraindications; 2. Suffering from serious heart, brain, lung, liver, kidney, blood diseases; 3. Pregnant or lactating women; 4. Combined with other diseases, researchers will not be able to evaluate the efficacy, or unlikely to complete the expected follow-up of patients; 5. The researchers believe that there is any inappropriate stituation.

Design outcomes

Primary

Measure	Time frame
Harris hip score;Ficat staging;Steinberg staging;	—

Countries

China

Contacts

Public ContactWang Aimin

Trauma2@163.com+86 13308302730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026